Pharma
Follow
Find
40.8K views | +2 today
 
Scooped by Andrew Spong
onto Pharma
Scoop.it!

Three IBM patents that will inform future health

Three IBM patents that will inform future health | Pharma | Scoop.it

Three recent IBM patents that will inform future health:

 

1. System and method for providing answers to questions does exactly what it sounds like. Much like you can now ask Siri on your iPhone about the weather, IBM has developed a semantic system for understanding questions asked by a person and then providing an answer in context. But IBM's system aims to be much more flexible than Siri, generating “candidate answers” that are the most likely responses even as the question is being asked, then delivering the answer that best fits the inquiry. It's how IBM's Watson creamed Ken Jennings on Jeopardy! U.S. Patent #8,275,803 filed September 25, 2012.

 

2. Electronic learning synapse with spike-timing dependent plasticity using unipolar memory-switching elements is an effort to mimic the human brain with a computer. More specifically, it's a system for microchips to emulate your brain's synapses. It's part of the research that's come out of IBM's SyNAPSE project that is working to reproduce the architecture of the brain, which is backed by Pentagon funding to the tune of $21 million in its current phase. U.S. Patent #8,250,010 filed Aug. 21, 2012.

 

3. Thin substrate fabrication using stress-induced substrate spalling is a low-cost semiconductors material to allow for thin and flexible products. Sure that could mean biomedical or wearable technology applications, but it could also mean some sort of electricity-carrying android skin. Not only will this manufacturing method be capable of making a solar-powered cell, it will do it cheaply. U.S. Patent #8,247,261 filed August 21, 2012.

more...
No comment yet.

From around the web

Pharma
Curating the writing of pharma's digital prescription
Curated by Andrew Spong
Your new post is loading...
Your new post is loading...
Rescooped by Andrew Spong from Patient
Scoop.it!

Healthcare is getting better. Let's talk about what you can do to make it even better, faster.

Healthcare is getting better. Let's talk about what you can do to make it even better, faster. | Pharma | Scoop.it

Click on the link above to contact Andrew Spong, Managing Director, STweM Ltd.

more...
Scooped by Andrew Spong
Scoop.it!

Five steps to building successful digital health interventions

Five steps to building successful digital health interventions | Pharma | Scoop.it

Context. Interoperability. Physician (and patient, presumably) 'engagement'. Evidence. Scale.

Andrew Spong's insight:

All factors worth bearing in mind, certainly, but in a sense this article is simply a reminder that every potential intervention needs to be considered on its merits, and that potentially successful solutions reside in the middle of a complex set of interrelations.

 

Overlooking any one of them is likely to consign your efforts to failure.

 

Oh, and good luck with 'interoperability'.

 

Who can really be said to have 'cracked' this yet, beyond marketing spin?

 

A 'Gordian Knot' solution that addresses the difficulties of legacy providers' EHR interoperability by severing ties with them altogether, and taking a consumer-led view by using the patient's own healthcare records seems only a generation or two of devices away at this point.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Six ways social media affects your clinical trial - whether you like it, or not

Six ways social media affects your clinical trial - whether you like it, or not | Pharma | Scoop.it

Transparency; recruitment; information sharing; advocacy; learning; support.

 

In short, pretty much everything has changed -- and there's both good and bad, from multiple, and often highly challenging perspectives.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

"Social media and real-time support can be done by pharma, and it’s being done right before your eyes"

"Social media and real-time support can be done by pharma, and it’s being done right before your eyes" | Pharma | Scoop.it
Andrew Spong's insight:

Kai Gait, Global Digital Director, GSK, keeping it real, as usual.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Astellas hosts an app-focused Innovation Challenge in association with New Scientist

Astellas hosts an app-focused Innovation Challenge in association with New Scientist | Pharma | Scoop.it

Astellas invites participants to 'Come up with an innovative app for healthy living that impresses [their] judges and your idea could become a reality!'

Andrew Spong's insight:

A positive, progressive idea. Great to see Astellas teaming up with New Scientist for this initiative, too

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

An overview of pharma's health accelerator initiatives and startup support

An overview of pharma's health accelerator initiatives and startup support | Pharma | Scoop.it

Merck, Bayer, GSK, Novartis, Janssen and more are all running digital health accelerator support programmes for startups

more...
Jim Murphy's curator insight, September 12, 8:53 AM

Incubating only works if the seeds get planted.  When these companies actually bring these solutions to market then it will be more than a branding gimmick.  

Scooped by Andrew Spong
Scoop.it!

Apple needs healthcare and medical tech companies to help create reasons to wear their devices

Apple needs healthcare and medical tech companies to help create reasons to wear their devices | Pharma | Scoop.it

Apple is trying create 'an iPod experience' in healthcare driven by its wearables, but Apple's wearables need to do things significant enough to persuade health consumers to carry their products around with them.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Life-Printer "X" can create human tissue and medicines

Life-Printer "X" can create human tissue and medicines | Pharma | Scoop.it

A Singapore startup creates history today with the unveiling of a three-dimensional bio-printer which can produce human tissue, bacterial colonies, dietary supplements and medicine for biomedical and life sciences research.

Andrew Spong's insight:

Now imagine the genome-hacking, file-sharing bedroom coders of five years hence when there's consumer bio-printers are available...

 

 

 

 

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

PMCPA commissions The EarthWorks to develop an app to simplify the APBI Code of Practice

PMCPA commissions The EarthWorks to develop an app to simplify the APBI Code of Practice | Pharma | Scoop.it

The UK's Code of Practice regulator is turning to digital technology for a strategic communications programme that will see it launch a new app to simplify the ABPI Code next year. 

 

The PMCPA, which administers the Code, will work with Marlow-based agency The Earthworks to create a strategic communications programme that will also include content marketing on the PMCPA's website and through social media channels.  

 

Vicky Bewer, head of communications at the PMCPA, said: “We are excited about the PMCPA becoming more active in the digital space, with The EarthWorks helping us maximise social media and the quality content we already have.”  

 

The PMCPA has often struggled with its online presence, so anything that can raise its digital game will likely be welcomed by its stakeholders.

 

Through the new partnership The Earthworks will be promoting a strong and positive profile for the PMCPA's work in relation to the Code and helping build awareness of, and promote, the benefits of self-regulation to the industry, health professionals, patients and the public.

Andrew Spong's insight:

I'm pleased to see the PMCPA partnering with a trusted and capable service provider to get this important work done.

 

Good news for all stakeholders.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Deal between Google and Novartis will see the development of non-invasive smart lenses

Deal between Google and Novartis will see the development of non-invasive smart lenses | Pharma | Scoop.it

Google[x] and Novartis' eye care division Alcon will create smart lenses that feature "non-invasive sensors, microchips and other miniaturized electronics" and focus on two main areas.

 

The first will provide a way for diabetic patients to keep on top of their glucose levels by measuring the sugar levels in their tear fluid, feeding the data back to a smartphone or tablet. The second solution aims to help restore the eye's natural focus on near objects, restoring clear vision to those who are only farsighted (presbyopia).

 

Andrew Spong's insight:

Non-invasive, all-pervasive sensors in health: #NIAP begins here

more...
rob halkes's curator insight, July 16, 10:11 AM

This certainly is a logical follow up of earlier policy intentions by Mac and Samsung : the health world is changing indeed.

See here and here and here

Scooped by Andrew Spong
Scoop.it!

The pharma Singularity is near

The pharma Singularity is near | Pharma | Scoop.it

The pharma Singularity is near, and on the basis of the evidence that we have to hand, it appears it will be arriving a good deal sooner than 2045.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

If patients aren't responding to your digital activity, it's probably because they think it's no good

If patients aren't responding to your digital activity, it's probably because they think it's no good | Pharma | Scoop.it
Patients who are slow to respond to pharma's digital healthcare initiatives are not ignoring you. They just think that your existing services don't meet their needs, or are of poor quality, or both
more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Digitally Sick is back!

Digitally Sick is back! | Pharma | Scoop.it
Andrew Spong's insight:

A new pod from  the digital pharma podcast Digitally Sick  wherein the resident team of Faisal Ahmed (@cleverpeeps), Alex Butler (@alex__butler), and Andrew Spong (@andrewspong) consider what's new in pharma social media, communications to healthcare professionals, and big data.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Pharma companies have many apps, relatively few downloads

Pharma companies have many apps, relatively few downloads | Pharma | Scoop.it
more...
Scooped by Andrew Spong
Scoop.it!

Involving people with lived experience: time to choose, because you can't support this, *and* still attend digital pharma conferences

Involving people with lived experience: time to choose, because you can't support this, *and* still attend digital pharma conferences | Pharma | Scoop.it

"A patient and carer viewpoint [will be] represented in every single session and workshop throughout the day, [and] we will be involving people with lived experience in other areas across the conference, including as speakers, chairs and mentors."

Andrew Spong's insight:

There are many reasons to want to attend healthcare conferences.

 

However, when there are options like this available, it's verging on reprehensible for anyone in the pharmaceutical industry to continue to support the lame duck, 'Usual Suspect' digital pharma conferences that reiterate themselves year after year, celebrating their repetition as though having done the same thing for eight years were an achievement rather than an embarrassment.

 

If you're serious about putting the patient at the centre of what you do, you *have* to go to conferences that put the patient at the centre of their programme -- not ones that pay lip service to 'patient engagement' in the absence of their eponymous subjects, and brazenly focus on patients as 'targets' and 'opportunities' rather than as people.


It's time to choose.


Do the right thing.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Mobile: transcending borders, rendering regulatory frameworks impotent

Mobile: transcending borders, rendering regulatory frameworks impotent | Pharma | Scoop.it

By 2017, 85% of the world’s population is expected to be covered by a commercial mobile signal.

 

Transcending state borders, mobile apps bring about a lot interesting questions for anyone studying regulatory frameworks and state-based policy....

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Six finalists announced in the 'Digital pharmaceutical company of the year' category of the PM Society Digital Media Awards 2014

Six finalists announced in the 'Digital pharmaceutical company of the year' category of the PM Society Digital Media Awards 2014 | Pharma | Scoop.it

Bayer, Boehringer Ingelheim, Genentech (Roche), GSK, Novartis and Sanofi have been shortlisted as finalists in the 'Digital pharmaceutical company of the year' category of this year's PM Society Digital Media Awards

Andrew Spong's insight:

I was pleased that STweM was able to work with our partners Symplur to compile the data behind this year's 'Digital pharmaceutical company of the year' category.

 

Results were derived by collating all tweets published in 2013 using the top ten hashtags in Symplur's Healthcare Hashtag Project associated with ten leading causes of mortality.

 

The top pharma companies within each disease area were identified according to the frequency with which they were mentioned.

 

The final results were determined by subsequently identifying those companies which featured most often in each category, weighting by rank, and ordering accordingly.


The winner will be announced on 25 September. I was kindly asked to present the award by the PM Society, but will be out of the country. PM Society co-chair Carwyn Jones has graciously offered to do the honours in my absence.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Patients, pharma, conferences, and the thorny question of 'Return On Investment' in the social age

Patients, pharma, conferences, and the thorny question of 'Return On Investment' in the social age | Pharma | Scoop.it

The evergreen question of what constitutes 'ROI' for pharma in being seen to actively participate in the healthcare conversation on the social web around conference is addressed from many angles in this @CancerGeek article, which reflects on Thomas Lee of Symplur's recent MedX presentation.

 

Do also be sure to read the productive exchanges in the comments.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

It's time for socially-competent US pharma companies to stop DTC advertising

It's time for socially-competent US pharma companies to stop DTC advertising | Pharma | Scoop.it

Why might socially-competent US pharma companies wish to withdraw from DTC marketing?

 

And which of them are ready to do so?

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

What happened when Sanofi US put patients, not products, at the centre of their social strategy

What happened when Sanofi US put patients, not products, at the centre of their social strategy | Pharma | Scoop.it

Sanofi US decided to make the centre of their social strategy their patients, not their products.

 

"We're publishing content by the people, for the people," says Director of Patients Insights Laura Kolodjeski (@lkolodjeski).

 

"It's not to market our products, but to enhance our overall value to our customers"

 

Ms. Kolodjeski explains the approach Sanofi tool to designing "The DX: The Diabetes Experience" (http://diabetes.sanofi.us/), Sanofi US's  content hub for people living with diabetes:

 

"We created The DX to offer a place for the community to engage around life and the aspect of that life with diabetes. We did not want it to be about diabetes, and we certainly did not want it to be about diabetes treatments"

Andrew Spong's insight:

As anyone who follows the content I share will know, I've been a long-time admirer of Sanofi's iterative approach to connecting with communities of interest on the social web.

 

This is just another example.

 

It is important that pharma companies situate their activities in a broader healthcare ecosystem in this manner rather than bringing isolated 'first in class' activities to digital environments which appear to be more about the organisers' desire to place themselves at the centre of a healthcare egosystem.

more...
Thierry Le Magny's curator insight, August 7, 2:34 AM

Great initiative!

Scooped by Andrew Spong
Scoop.it!

Tablets vs. paper: how the Philippines halved the cost of healthcare delivery

Tablets vs. paper: how the Philippines halved the cost of healthcare delivery | Pharma | Scoop.it

A project in the Philippines has reduced the cost of collecting healthcare information and delivering public health messages to the poorest families by almost half over five years, a university study has found.

 

ACCESS, a non-profit think tank, has trained the government’s community health teams to collect health information on families using tablets, replacing paper forms which they had been using since 2011.

 

The health workers can now use a mobile and web app to summarise the data collected and automatically generate reports. The City Health Office can also directly access the reports online and share them with other government agencies.

Andrew Spong's insight:

A lesson in how effective technology can be in delivering great results from an HEOR perspective when legacy EHR vendors don't get in the way.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Pharma social media: five best practice examples

Pharma social media: five best practice examples | Pharma | Scoop.it

Phil Baumann proposes that pharma companies planning on supporting activities in social environments:

 

Identify clear and specific objectives that lend themselves to social media outletsMatch the social media platform to the brand’s specific objectivesDevelop guidelines and workflows for interactions and engagement opportunitiesEnsure that qualified staff manage all of your social media activitiesWork with vendors who understand customer care and know how to handle all aspects of social media including adverse event identification, correction of misinformation and patient engagement within the unique parameters of each social media platform
Andrew Spong's insight:

Appropriate aims. Adequate preparation. Purposeful participation. Sure-footed execution.

 

It's a shame that more companies don't feel compelled to follow modest, achievable, and productive agendas such as Phil sets out here.

 

At this stage, one can only assume that it is a lack of desire mixed with a fear of career-limiting mistakes.

 

The manifestation of either of those conditions would be a pity, yet the likelihood is that both of them pertain.

 

People working in the pharmaceutical industry are stewards of more than just their own careers. If they're risk averse, it may be better to find another industry.

 

The pharmaceutical industry matters too much for it to be led by the faint-hearted.

 

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Industry usage of social media in clinical research

Industry usage of social media in clinical research | Pharma | Scoop.it
The Tufts Center for the Study of Drug Development convened 20 pharmaceutical companies and contract research organizations (CROs) to provide insight into how social media was being used in drug research. Some of the findings highlight the worries that pharmaceutical companies have when dealing with social media in general.
more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Social entailments: the gulf between patient goals and pharma actions

Social entailments: the gulf between patient goals and pharma actions | Pharma | Scoop.it

Pharma’s participation in digital environments has a price of entry, namely recognising and responding to the necessary consequences of their doing so.

 

Attending to the items described in this post would take any pharma activity in a digital environment some distance towards requiting this debt, although it can never settle it in full.

 

Transactional relationships in digital environments give and take, indefinitely.

 

There is no final reckoning.

 

However, in order to discern where the industry is in debt, and where it may even occasionally be in credit, with regard to patient opinion, pharma need only do one thing:

 

Ask.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

FDA: Regulators can't scale to police mobile health apps

FDA: Regulators can't scale to police mobile health apps | Pharma | Scoop.it
A senior advisor to the FDA said the agency couldn't possibly scale up to meet the challenge of policing the hundreds of new apps appearing every month.
more...
Joel Finkle's curator insight, July 7, 9:05 AM

This is somewhat sad -- but perhaps those of us who do submit for review can badge our apps with "FDA Approved!"